Press ReleasesArchived Press ReleasesFor information regarding press releases please contact us at: Phone: (402) 452-5437 Fax: (402) 452-5461 E-mail: investorrelations@transgenomic.com DisclaimerThe following historical press releases contain statements that reflected management's views and estimates of future economic circumstances, industry conditions, company performance and financial results applicable on the dates they were first issued. Investors should not assume that statements made in these documents remain accurate and complete as of any later date. Such statements were and remain subject to certain factors, risks and uncertainties, including those described in Transgenomic, Inc.'s reports to the Securities and Exchange Commission. Any change in such factors, risks and uncertainties could have caused the actual results, events and performance to differ materially from those referred to in such statements. Transgenomic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any of these documents to reflect any change in Transgenomic's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements were based. Available Archives2009 Archive| December 17, 2009 | View | Transgenomic, Inc. Executes License Option Agreement for Parkinson’s Disease Diagnostic Markers with Gene Solutions, LLC | | | | December 8, 2009 | View | Transgenomic Announces the Commercial Launch of SURVEYOR® Scan K-RAS Mutation Detection Kit | | | | November 5, 2009 | View | Transgenomic, Inc. Reports Third Quarter 2009 Results | | | | November 5, 2009 | View | Reminder Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast | | | | October 29, 2009 | View | Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast | | | | October 8, 2009 | View | Transgenomic Signs Exclusive License for Cold-PCR Technology from the Dana-Farber Cancer Institute | | | | September 2, 2009 | View | Transgenomic and Power3 Medical Report Identification of Abnormal Serum Proteins in Parkinson’s Disease | | | | August 12, 2009 | View | Transgenomic, Inc. Reports Second Quarter 2009 Results | | | | August 12, 2009 | View | Reminder: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast | | | | August 6, 2009 | View | Webcast Alert: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast | | | | May 22, 2009 | View | Transgenomic, Inc. Announces Appointment of New Board Members | | | | May 13, 2009 | View | Transgenomic, Inc. Reports First Quarter 2009 Results | | | | May 13, 2009 | View | Reminder: Transgenomic Inc. Announces First Quarter 2009 Earnings Release Conference Call Webcast | | | | May 11, 2009 | View | Transgenomic and Power3 Medical Introduce NuroPro® Tests for Alzheimer’s and Parkinson’s Diseases at AAN Annual Meeting | | | | May 7, 2009 | View | Webcast Alert: Transgenomic Inc. Announces First Quarter 2009 Earnings Release Conference Call Webcast | | | | April 7, 2009 | View | Transgenomic Completes Licensing Option with Dana-Farber Cancer Institute on Cold-PCR for Enrichment of DNA Mutations | | | | April 2, 2009 | View | Polycystic Kidney Disease Assay at Cornell University uses Transgenomic’s Surveyor Nuclease & WAVE Technology | | | | March 18, 2009 | View | Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results | | | | March 18, 2009 | View | Reminder - Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2008 Earnings Release Conference Call Webcast | | | | March 11, 2009 | View | Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2008 Earnings Release Conference Call Webcast | | | | March 5, 2009 | View | Transgenomic Awarded Clinical Laboratory Certification in California | | | | February 23, 2009 | View | Webcast Alert Cancellation: Transgenomic Inc. Cancels Fourth Quarter 2008 Earnings Release Conference Call Webcast | | | | February 18, 2009 | View | Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2008 Earnings Release Conference Call Webcast | | | | February 2, 2009 | View | Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test | | |
|